AN2 THERAPEUTICS INC (ANTX) Stock Analyst Ratings
NASDAQ:ANTX - Nasdaq - US0373261058 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 48% to ANTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.7. This target is 57.41% above the current price.
ANTX was analyzed by 8 analysts. The buy percentage consensus is at 48. So analysts seem to be rather neutral about ANTX.
In the previous month the buy percentage consensus was at a similar level.
ANTX was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-05 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-03-26 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-25 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-03 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-11-19 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-11-18 | TD Cowen | Downgrade | Buy -> Hold |
| 2024-08-09 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-07-03 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2024-05-16 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2024-04-02 | JMP Securities | Upgrade | Market Perform -> Market Outperform |
| 2024-04-01 | Oppenheimer | Reiterate | Perform -> Perform |
| 2024-02-13 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-02-12 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2024-02-12 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2024-02-12 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2024-01-04 | JMP Securities | Initiate | Market Outperform |
| 2023-03-30 | Oppenheimer | Maintains | Outperform |
| 2022-11-14 | SVB Leerink | Maintains | Outperform |
| 2022-04-19 | Oppenheimer | Initiate | Outperform |
| 2022-04-19 | Cowen & Co. | Initiate | Outperform |
| 2022-04-19 | Evercore ISI Group | Initiate | Outperform |